Skip to Main Content
Skip Nav Destination

The epilogue returns to the ethical quandaries of a technology that, by seeking a pluripotent fate, may indeed open us up to a multitude of “unknown unknowns.” The author contrasts the two Asian models of biomedical entrepreneurialism. Biopolis deploys the ethnic heuristic to shape a transborder biomedical zone and act as a “DNA bridge” to American cosmopolitan science. The author argues that Singaporean humanists, social scientists and philosophers need to start a public conversation about the wide-ranging implications of experiments with life in their midst. What are the benefits and uncertainties of sequencing DNA and perturbing cells as lifesaving therapies...

This content is only available as PDF.
You do not currently have access to this chapter.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal